Growth Metrics

Bristol Myers Squibb (BMYMP) Total Non-Current Liabilities (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Total Non-Current Liabilities for 17 consecutive years, with $66.5 billion as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 7.33% to $66.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $66.5 billion through Dec 2025, down 7.33% year-over-year, with the annual reading at $66.5 billion for FY2025, 7.33% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $66.5 billion at Bristol Myers Squibb, down from $72.8 billion in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $75.8 billion in Q1 2024, with the low at $55.6 billion in Q2 2023.
  • Average Total Non-Current Liabilities over 5 years is $65.5 billion, with a median of $66.3 billion recorded in 2021.
  • The sharpest move saw Total Non-Current Liabilities decreased 13.03% in 2023, then skyrocketed 35.92% in 2024.
  • Over 5 years, Total Non-Current Liabilities stood at $66.0 billion in 2021, then dropped by 10.4% to $59.1 billion in 2022, then grew by 0.24% to $59.3 billion in 2023, then grew by 21.08% to $71.7 billion in 2024, then fell by 7.33% to $66.5 billion in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $66.5 billion, $72.8 billion, and $72.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.